Under a deal struck Friday, the Senate won't vote until early next year on a controversial bill to loosen restrictions on publicly funded embryonic stem cell studies. Before the agreement, the deal's sponsors had said they would hold up a must-pass spending measure until lawmakers voted on the research. The deal releases Senate Majority Leader Bill Frist from his promise to hold a vote this year on the measure. The bill is controversial because the research process destroys fertilized human embryos.
October 24, 2005 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
The Senate won’t vote until early next year on a bill to loosen restrictions on publicly funded embryonic stem cell studies, under a deal struck Friday by the sponsors.
“The majority leader has committed to bringing it up as one of the first items next year,” Sen. Arlen Specter, R-Pa., the stem cell bill’s lead sponsor, announced on the Senate floor.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
